| Year |
Citation |
Score |
| 2023 |
He X, Wang X, Wang H, Wang T, Yang F, Chen Y, Pei Z, Bai Y, Li W, Wu Z, Chen G. NeuroD1 Regulated Endothelial Gene Expression to Modulate Transduction of AAV-PHP.eB and Recovery Progress after Ischemic Stroke. Aging and Disease. PMID 38270116 DOI: 10.14336/AD.2023.1213 |
0.553 |
|
| 2021 |
Tang Y, Wu Q, Gao M, Ryu E, Pei Z, Kissinger ST, Chen Y, Rao AK, Xiang Z, Wang T, Li W, Chen G, Chubykin AA. Restoration of Visual Function and Cortical Connectivity After Ischemic Injury Through NeuroD1-Mediated Gene Therapy. Frontiers in Cell and Developmental Biology. 9: 720078. PMID 34490268 DOI: 10.3389/fcell.2021.720078 |
0.607 |
|
| 2020 |
Zhang L, Lei Z, Guo Z, Pei Z, Chen Y, Zhang F, Cai A, Mok G, Lee G, Swaminathan V, Wang F, Bai Y, Chen G. Development of Neuroregenerative Gene Therapy to Reverse Glial Scar Tissue Back to Neuron-Enriched Tissue. Frontiers in Cellular Neuroscience. 14: 594170. PMID 33250718 DOI: 10.3389/fncel.2020.594170 |
0.732 |
|
| 2020 |
Wu Z, Parry M, Hou XY, Liu MH, Wang H, Cain R, Pei ZF, Chen YC, Guo ZY, Abhijeet S, Chen G. Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease. Nature Communications. 11: 1105. PMID 32107381 DOI: 10.1038/S41467-020-14855-3 |
0.716 |
|
| 2020 |
Chubykin A, Tang Y, Wu Q, Ryu E, Pei Z, Chen Y, Chen G. Synaptic circuit restoration and functional recovery in the mouse visual cortex after ischemic injury and direct
in vivo
reprogramming of astrocytes into neurons The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05621 |
0.511 |
|
| 2019 |
Chen YC, Ma NX, Pei ZF, Wu Z, Do-Monte FH, Keefe S, Yellin E, Chen MS, Yin JC, Lee G, Minier-Toribio A, Hu Y, Bai YT, Lee K, Quirk GJ, et al. A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron Conversion. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31551137 DOI: 10.1016/J.Ymthe.2019.09.003 |
0.709 |
|
| 2014 |
Ju TC, Chen HM, Chen YC, Chang CP, Chang C, Chern Y. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease. Biochimica Et Biophysica Acta. 1842: 1668-80. PMID 24946181 DOI: 10.1016/j.bbadis.2014.06.012 |
0.314 |
|
| 2014 |
Hsiao HY, Chiu FL, Chen CM, Wu YR, Chen HM, Chen YC, Kuo HC, Chern Y. Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease. Human Molecular Genetics. 23: 4328-44. PMID 24698979 DOI: 10.1093/hmg/ddu151 |
0.323 |
|
| 2014 |
Guo Z, Zhang L, Wu Z, Chen Y, Wang F, Chen G. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model. Cell Stem Cell. 14: 188-202. PMID 24360883 DOI: 10.1016/J.Stem.2013.12.001 |
0.719 |
|
| 2013 |
Hsiao HY, Chen YC, Chen HM, Tu PH, Chern Y. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease. Human Molecular Genetics. 22: 1826-42. PMID 23372043 DOI: 10.1093/Hmg/Ddt036 |
0.406 |
|
| 2008 |
Tang X, Fu Dh, Yang Sh, Chen Yc, Li Q, Yu Cn, Xu Wh, Li J, Ye Sn. Assessment of the expression profile during the entochondrostosis of vascular endothelial growth factor in bone morphogenetic protein 2 induced osteogenesis Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 46: 614-617. PMID 18844060 |
0.337 |
|
| Show low-probability matches. |